⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ATYR News
aTyr Pharma, Inc. Common Stock
Form 8-K
sec.gov
ATYR
aTyr Pharma to Present Subgroup Analysis of Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis at WASOG 2026
globenewswire.com
ATYR
Form 8-K
sec.gov
ATYR
Form 8-K
sec.gov
ATYR
Sensorion Appoints Fred Chereau as Chief Executive Officer
businesswire.com
ATYR
Form 8-K
sec.gov
ATYR
aTyr Pharma Announces First Quarter 2026 Results and Provides Corporate Update
globenewswire.com
ATYR
aTyr Pharma to Participate in Upcoming Investor Conferences
globenewswire.com
ATYR
Form 8-K
sec.gov
ATYR
aTyr Pharma Provides Regulatory and Clinical Update for Efzofitimod in Pulmonary Sarcoidosis Following FDA Type C Meeting
globenewswire.com
ATYR